Identification of Three Core Secretome Genes Associated with Immune Infiltration in High Tumor Mutation Burden Across 14 Major Solid Tumors

References

• Brandi J, Manfredi M, Speziali G, et al. Proteomic approaches to decipher cancer cell secretome. Semin Cell Dev Biol. 2018;78:93–101. doi:10.1016/j.semcdb.2017.06.030
   PubMed Web of Science ®Google Scholar
• Madden EC, Gorman AM, Logue SE, et al. Tumour cell secretome in chemoresistance and tumour recurrence. Trends Cancer. 2020;6(6):489–505. doi:10.1016/j.trecan.2020.02.020
   PubMed Web of Science ®Google Scholar
• Paltridge JL, Belle L, Khew-Goodall Y. The secretome in cancer progression. Biochim Biophys Acta. 2013;1834(11):2233–2241. doi:10.1016/j.bbapap.2013.03.014
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253. doi:10.15252/embr.201439246
   PubMed Web of Science ®Google Scholar
• Chen X, Xu C, Hong S, et al. Immune cell types and secreted factors contributing to inflammation-to-cancer transition and immune therapy response. Cell Rep. 2019;26(7):1965–1977.e4. doi:10.1016/j.celrep.2019.01.080
   PubMed Web of Science ®Google Scholar
• Pitt JM, Marabelle A, Eggermont A, et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482–1492. doi:10.1093/annonc/mdw168
   PubMed Web of Science ®Google Scholar
• Püschel F, Favaro F, Redondo-Pedraza J, et al. Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells. Proc Natl Acad Sci U S A. 2020;117(18):9932–9941. doi:10.1073/pnas.1913707117
   PubMed Web of Science ®Google Scholar
• Fang S, Xu T, Xiong M, et al. Role of immune response, inflammation, and tumor immune response-related cytokines/chemokines in melanoma progression. J Invest Dermatol. 2019;139(11):2352–2358.e3. doi:10.1016/j.jid.2019.03.1158
   PubMed Web of Science ®Google Scholar
• Robinson JL, Feizi A, Uhlén M, et al. A systematic investigation of the malignant functions and diagnostic potential of the cancer secretome. Cell Rep. 2019;26(10):2622–2635.e5. doi:10.1016/j.celrep.2019.02.025
   PubMed Web of Science ®Google Scholar
• Goodman AM, Kato S, Bazhenova L, et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther. 2017;16(11):2598–2608. doi:10.1158/1535-7163.MCT-17-0386
   PubMed Web of Science ®Google Scholar
• Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30(1):44–56. doi:10.1093/annonc/mdy495
   PubMed Web of Science ®Google Scholar
• Cao D, Xu H, Xu X, et al. High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients. Oncoimmunology. 2019;8(9):e1629258. doi:10.1080/2162402X.2019.1629258
   PubMed Web of Science ®Google Scholar
• McNamara MG, Jacobs T, Lamarca A, et al. Impact of high tumor mutational burden in solid tumors and challenges for biomarker application. Cancer Treat Rev. 2020;89:102084. doi:10.1016/j.ctrv.2020.102084
   PubMed Web of Science ®Google Scholar
• Wang X, Li M. Correlate tumor mutation burden with immune signatures in human cancers. BMC Immunol. 2019;20(1):4. doi:10.1186/s12865-018-0285-5
   PubMed Web of Science ®Google Scholar
• Acs B, Ahmed FS, Gupta S, et al. An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma. Nat Commun. 2019;10(1):5440. doi:10.1038/s41467-019-13043-2
   PubMed Web of Science ®Google Scholar
• Paijens ST, Vledder A, de Bruyn M, et al. Tumor-infiltrating lymphocytes in the immunotherapy era. Cell Mol Immunol. 2020. doi:10.1038/s41423-020-00565-9
   PubMed Web of Science ®Google Scholar
• Ge P, Wang W, Li L, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomed Pharmacother. 2019;118:109228. doi:10.1016/j.biopha.2019.109228
   PubMed Web of Science ®Google Scholar
• Zhang C, Zheng JH, Lin ZH, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Aging. 2020;12(4):3486–3501. doi:10.18632/aging.102824
   PubMedGoogle Scholar
• Li B, Geng R, Wu Q, et al. Alterations in immune-related genes as potential marker of prognosis in breast cancer. Front Oncol. 2020;10:333. doi:10.3389/fonc.2020.00333
   PubMed Web of Science ®Google Scholar
• D’Angelo A, Sobhani N, Roviello G, et al. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. PLoS One. 2019;14(8):e0219566. doi:10.1371/journal.pone.0219566
   PubMed Web of Science ®Google Scholar
• Lapuente-Santana Ó, van Genderen M, Hilbers PAJ, et al. Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. Patterns. 2021;2(8):100293. doi:10.1016/j.patter.2021.100293
   PubMedGoogle Scholar
• Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821. doi:10.1038/s41423-020-0488-6
   PubMed Web of Science ®Google Scholar
• Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651–668. doi:10.1038/s41577-020-0306-5
   PubMed Web of Science ®Google Scholar
• Mounir M, Lucchetta M, Silva TC, et al. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019;15(3):e1006701. doi:10.1371/journal.pcbi.1006701
   PubMed Web of Science ®Google Scholar
• Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–1756. doi:10.1101/gr.239244.118
   PubMed Web of Science ®Google Scholar
• Liu SH, Shen PC, Chen CY, et al. DriverDBv3: a multi-omics database for cancer driver gene research. Nucleic Acids Res. 2020;48(D1):D863–D870. doi:10.1093/nar/gkz964
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Seliger B. Basis of PD1/PD-L1 Therapies. J Clin Med. 2019;8(12):E2168. doi:10.3390/jcm8122168
   PubMed Web of Science ®Google Scholar
• Zuo S, Wei M, Wang S, Dong J, Wei J. Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma. Front Immunol. 2020;11:1218. doi:10.3389/fimmu.2020.01218
   PubMed Web of Science ®Google Scholar
• O’Donnell JS, Massi D, Teng MWL, et al. PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol. 2018;48:91–103. doi:10.1016/j.semcancer.2017.04.015
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Marin-Acevedo JA, Dholaria B, Soyano AE, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018;11(1):39. doi:10.1186/s13045-018-0582-8
   PubMed Web of Science ®Google Scholar
• Kather JN, Suarez-Carmona M, Charoentong P, et al. Topography of cancer-associated immune cells in human solid tumors. Elife. 2018;7. doi:10.7554/eLife.36967
   PubMed Web of Science ®Google Scholar
• Hu FF, Liu CJ, Liu LL, et al. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 2020. doi:10.1093/bib/bbaa176
   Web of Science ®Google Scholar
• Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517–2526. doi:10.1056/NEJMoa1104621
   PubMed Web of Science ®Google Scholar
• Qin S, Xu L, Yi M, et al. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol Cancer. 2019;18(1):155. doi:10.1186/s12943-019-1091-2
   PubMed Web of Science ®Google Scholar
• Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer. 2017;117(4):451–460. doi:10.1038/bjc.2017.220
   PubMed Web of Science ®Google Scholar
• Hendry S, Salgado R, Gevaert T, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol. 2017;24(6):311–335. doi:10.1097/PAP.0000000000000161
   PubMed Web of Science ®Google Scholar
• Poh AR, Ernst M. Targeting macrophages in cancer: from bench to bedside. Front Oncol. 2018;8:49. doi:10.3389/fonc.2018.00049
   PubMed Web of Science ®Google Scholar
• Qiu SQ, Waaijer SJH, Zwager MC, et al. Tumor-associated macrophages in breast cancer: innocent bystander or important player? Cancer Treat Rev. 2018;70:178–189. doi:10.1016/j.ctrv.2018.08.010
   PubMed Web of Science ®Google Scholar
• Sánchez-Alonso S, Setti-Jerez G, Arroyo M, et al. A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy. J Immunother Cancer. 2020;8(2):e001187. doi:10.1136/jitc-2020-001187
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Galli F, Aguilera JV, Palermo B, et al. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. J Exp Clin Cancer Res. 2020;39(1):89. doi:10.1186/s13046-020-01586-y
   PubMed Web of Science ®Google Scholar
• Berraondo P, Sanmamed MF, Ochoa MC, et al. Cytokines in clinical cancer immunotherapy. Br J Cancer. 2019;120(1):6–15. doi:10.1038/s41416-018-0328-y
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86–104. doi:10.3322/caac.21596
   PubMed Web of Science ®Google Scholar
• Chulpanova DS, Kitaeva KV, Green AR, et al. Molecular aspects and future perspectives of cytokine-based anti-cancer Immunotherapy. Front Cell Dev Biol. 2020;8:402. doi:10.3389/fcell.2020.00402
   PubMed Web of Science ®Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–572. doi:10.1038/nri.2017.49
   PubMed Web of Science ®Google Scholar
• Qi B, Liu H, Dong Y, et al. The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma. PeerJ. 2020;8:e9736. doi:10.7717/peerj.9736
   PubMed Web of Science ®Google Scholar
• Liang L, Zhu JH, Chen G, et al. Prognostic values for the mRNA expression of the ADAMTS family of genes in gastric cancer. J Oncol. 2020;2020:9431560. doi:10.1155/2020/9431560
   PubMed Web of Science ®Google Scholar
• Li Y, Su Z, Wei B, et al. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis. Math Biosci Eng. 2021;18(5):5921–5942. doi:10.3934/mbe.2021296
   PubMed Web of Science ®Google Scholar
• Jiang X, Wu M, Xu X, et al. COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer. Mol Med Rep. 2019;20(4):3103–3112. doi:10.3892/mmr.2019.10548
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen W, Dai X, et al. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer. Int Immunopharmacol. 2020;87:106798. doi:10.1016/j.intimp.2020.106798
   PubMed Web of Science ®Google Scholar
• Cai S, Guo X, Huang C, et al. Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma. J Transl Med. 2021;19(1):361. doi:10.1186/s12967-021-03031-w
   PubMed Web of Science ®Google Scholar
• Yin W, Zhu H, Tan J, et al. Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell Int. 2021;21(1):276. doi:10.1186/s12935-021-01982-0
   PubMed Web of Science ®Google Scholar
• Ren X, Chen X, Fang K, et al. COL5A2 promotes proliferation and invasion in prostate cancer and is one of seven gleason-related genes that predict recurrence-free survival. Front Oncol. 2021;11:583083. doi:10.3389/fonc.2021.583083
   PubMed Web of Science ®Google Scholar
• Luan H, Zhang C, Zhang T, et al. Identification of key prognostic biomarker and its correlation with immune infiltrates in pancreatic ductal adenocarcinoma. Dis Markers. 2020;2020:8825997. doi:10.1155/2020/8825997
   PubMed Web of Science ®Google Scholar